Long-Chain Fatty Acid Oxidation Disorders Online Disease Monitoring Program

NCT04812106 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2022-11-18

No results posted yet for this study

Summary

The objectives of this study are to characterize the disease impact, the disease management and resource utilization, and provide benefits to the LC-FAOD community, by use of a convenient online platform for participants (or caregivers) to self-report information.

Conditions

  • Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)

Interventions

OTHER

No Intervention

No Intervention

Sponsors & Collaborators

Principal Investigators

  • Medical Director · Ultragenyx Pharmaceutical Inc

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-25
Primary Completion
2022-10-27
Completion
2022-10-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04812106 on ClinicalTrials.gov